Early recipient chimerism testing in the T- and NK-cell lineages for risk assessment of graft rejection in pediatric patients undergoing allogeneic stem cell transplantation (Q50790158)

From Wikidata

Jump to navigation Jump to search

scientific article published on 16 September 2011

Language	Label	Description	Also known as
English	Early recipient chimerism testing in the T- and NK-cell lineages for risk assessment of graft rejection in pediatric patients undergoing allogeneic stem cell transplantation	scientific article published on 16 September 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/21926962

Early recipient chimerism testing in the T- and NK-cell lineages for risk assessment of graft rejection in pediatric patients undergoing allogeneic stem cell transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/21926962

Christina Peters

8

object named as

C Peters

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/21926962

author name string

S Breuer

1

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/21926962

S Preuner

2

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/21926962

G Fritsch

3

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/21926962

H Daxberger

4

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/21926962

M Koenig

5

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/21926962

U Poetschger

6

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/21926962

A Lawitschka

7

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/21926962

G Mann

9

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/21926962

T Lion

10

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/21926962

S Matthes-Martin

11

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/21926962

publication date

16 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/21926962

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/21926962

26

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/21926962

3

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/21926962

509-519

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/21926962

Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Vienna experience

1 reference

https://api.crossref.org/works/10.1038/LEU.2011.244

21 January 2018

Summary: reports on quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection

1 reference

https://api.crossref.org/works/10.1038/LEU.2011.244

21 January 2018

The RSD code: proposal for a nomenclature of allelic configurations in STR-PCR-based chimerism testing after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038/LEU.2011.244

21 January 2018

Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Bl

1 reference

https://api.crossref.org/works/10.1038/LEU.2011.244

21 January 2018

How and when should we monitor chimerism after allogeneic stem cell transplantation?

1 reference

https://api.crossref.org/works/10.1038/LEU.2011.244

21 January 2018

Reduced intensity conditioning and allogeneic stem cell transplantation in childhood malignant and nonmalignant diseases

1 reference

https://api.crossref.org/works/10.1038/LEU.2011.244

21 January 2018

Increasing mixed chimerism and the risk of graft loss in children undergoing allogeneic hematopoietic stem cell transplantation for non-malignant disorders

1 reference

https://api.crossref.org/works/10.1038/LEU.2011.244

21 January 2018

Impact of T cell chimerism on clinical outcome in 117 patients who underwent allogeneic stem cell transplantation with a busulfan-containing reduced-intensity conditioning regimen

1 reference

https://api.crossref.org/works/10.1038/LEU.2011.244

21 January 2018

Significance of chimerism in hematopoietic stem cell transplantation: new variations on an old theme

1 reference

https://api.crossref.org/works/10.1038/LEU.2011.244

21 January 2018

Graft failure after allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038/LEU.2011.244

21 January 2018

The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038/LEU.2011.244

21 January 2018

Flow cytometric monitoring of hematopoietic reconstitution in myeloablated patients following allogeneic transplantation

1 reference

https://api.crossref.org/works/10.1038/LEU.2011.244

21 January 2018

Chimerism and outcomes after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038/LEU.2011.244

21 January 2018

Lack of utility of chimerism studies obtained 2-3 months after myeloablative hematopoietic cell transplantation for ALL.

1 reference

https://api.crossref.org/works/10.1038/LEU.2011.244

21 January 2018

Lineage-specific chimaerism after stem cell transplantation in children following reduced intensity conditioning: potential predictive value of NK cell chimaerism for late graft rejection

1 reference

https://api.crossref.org/works/10.1038/LEU.2011.244

21 January 2018

Analysis of donor-type chimerism in lineage-specific cell populations after allogeneic myeloablative and non-myeloablative stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038/LEU.2011.244

21 January 2018

Prognostic utility of routine chimerism testing at 2 to 6 months after allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038/LEU.2011.244

21 January 2018

Quantification of CD34 cells: comparison of methods

1 reference

https://api.crossref.org/works/10.1038/LEU.2011.244

21 January 2018

Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy?

1 reference

https://api.crossref.org/works/10.1038/LEU.2011.244

21 January 2018

Chimerism analysis within 6 months of allogeneic stem cell transplantation predicts relapse in acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1038/LEU.2011.244

21 January 2018

Lineage-specific engraftment and outcomes after T-cell-depleted peripheral blood stem cell transplant with Flu/Cy/TBI conditioning

1 reference

https://api.crossref.org/works/10.1038/LEU.2011.244

21 January 2018

Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038/LEU.2011.244

21 January 2018

Chimerism and clinical outcomes of 110 recipients of unrelated donor bone marrow transplants who underwent conditioning with low-dose, single-exposure total body irradiation and cyclophosphamide

1 reference

https://api.crossref.org/works/10.1038/LEU.2011.244

21 January 2018

Mixed hematopoietic chimerism at day 90 following allogenic myeloablative stem cell transplantation is a predictor of relapse and survival

1 reference

https://api.crossref.org/works/10.1038/LEU.2011.244

21 January 2018

Clinical utility of chimerism status assessed by lineage-specific short tandem repeat analysis: experience from four cases of allogeneic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038/LEU.2011.244

21 January 2018

Chimaerism analyses and subsequent immunological intervention after stem cell transplantation in patients with juvenile myelomonocytic leukaemia.

1 reference

https://api.crossref.org/works/10.1038/LEU.2011.244

21 January 2018

The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038/LEU.2011.244

21 January 2018

Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation (BSCT) using multiplex PCR amplification of short tandem repeat-markers

1 reference

https://api.crossref.org/works/10.1038/LEU.2011.244

7 January 2021

based on heuristic

inferred from DOI database lookup

Chimerism does not predict for outcome after alemtuzumab based conditioning

1 reference

https://api.crossref.org/works/10.1038/LEU.2011.244

7 January 2021

based on heuristic

inferred from DOI database lookup

Chimerism does not predict for outcome after alemtuzumab-based conditioning: lineage-specific analysis of chimerism of specific diseases may be more informative

1 reference

https://api.crossref.org/works/10.1038/LEU.2011.244

7 January 2021

based on heuristic

inferred from DOI database lookup

Chimerism testing after allogeneic stem cell transplantation: importance of timing and optimal technique for testing in different clinical-biological situations

1 reference

https://api.crossref.org/works/10.1038/LEU.2011.244

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of chimerism within specific leukocyte subsets for detection of residual or recurrent leukemia in pediatric patients after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038/LEU.2011.244

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical relevance of serial quantitative analysis of hematopoietic chimerism after allogeneic stem cell transplantation in children for severe aplastic anemia

1 reference

https://api.crossref.org/works/10.1038/LEU.2011.244

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of immunomodulatory treatment based on conventional and lineage-specific chimerism analysis in patients with myeloid malignancies after myeloablative allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038/LEU.2011.244

7 January 2021

based on heuristic

inferred from DOI database lookup

Children with myelodysplastic syndrome (MDS) and increasing mixed chimaerism after allogeneic stem cell transplantation have a poor outcome which can be improved by pre-emptive immunotherapy

1 reference

https://api.crossref.org/works/10.1038/LEU.2011.244

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up of persisting mixed chimerism after partially T cell-depleted allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038/LEU.2011.244

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictive factors and impact of full donor T-cell chimerism after reduced intensity conditioning allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038/LEU.2011.244

7 January 2021

based on heuristic

inferred from DOI database lookup

Full donor chimerism by day 30 after allogeneic peripheral blood progenitor cell transplantation is associated with a low risk of relapse in pediatric patients with hematological malignancies

1 reference

https://api.crossref.org/works/10.1038/LEU.2011.244

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/LEU.2011.244

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/21926962

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 March 2018

http://europepmc.org/abstract/MED/21926962

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50790158&oldid=2261415541"